Lexeo Therapeutics (LXEO) Interest & Investment Income (2022 - 2026)

Lexeo Therapeutics has reported Interest & Investment Income for 5 years, with the latest figure at $2.1 million in Q1 2026.

• Quarterly Interest & Investment Income rose 17708.33% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 19.63% YoY) and the FY2025 annual result came in at $6.1 million, down 18.87% from the prior year.
• Interest & Investment Income fell to $2.1 million in Q1 2026 per LXEO's latest filing, from $2.2 million in the prior quarter.
• Over five years, Interest & Investment Income peaked at $2.3 million in Q2 2024 and troughed at -$12000.0 in Q1 2025.
• A 5-year average of $1.2 million and a median of $1.3 million in 2025 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income tumbled 100.73% in 2025, then jumped 17708.33% in 2026.
• Over 5 years, Interest & Investment Income stood at $676000.0 in 2022, then jumped by 63.02% to $1.1 million in 2023, then surged by 32.94% to $1.5 million in 2024, then surged by 51.06% to $2.2 million in 2025, then fell by 4.52% to $2.1 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $2.1 million, $2.2 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.